TY - JOUR
T1 - West Nile virus
AU - Kramer, Laura D.
AU - Li, Jun
AU - Shi, Pei Yong
N1 - Funding Information:
We thank Dr Richard Kuhn for providing cryo-electron microscope images in figure 1 . We thank Dr Aashi Shah for his generous gift of figure 3, parts A and B and 3B . LDK's group is supported by NIH contract NO1AI254 90 and grant AI50758-01, and CDC grant U50/CCU220532-01. JL's group is supported by grants NINDS K08NS048204 and MDA4029. PYS's group is supported by NIH grants AI061193 and AI065562.
PY - 2007/2
Y1 - 2007/2
N2 - West Nile virus is a mosquito-borne flavivirus originally isolated in 1937 from the blood of a febrile woman in the West Nile province of Uganda. The virus is widely distributed in Africa, Europe, Australia, and Asia, and, since 1999, it has spread rapidly throughout the western hemisphere, including the USA, Canada, Mexico, and the Caribbean and into parts of Central and South America. Before 1994, outbreaks of West Nile virus were sporadic and occurred primarily in the Mediterranean region, Africa, and east Europe. Since 1994, outbreaks have occurred with a higher incidence of severe human disease, particularly affecting the nervous system. In North America, the virus has caused meningitis, encephalitis, and poliomyelitis, resulting in significant morbidity and mortality. The goal of this Review is to highlight recent advances in our understanding of West Nile virus virology, ecology, clinical disease, diagnosis, and development of potential vaccines and antiviral therapies.
AB - West Nile virus is a mosquito-borne flavivirus originally isolated in 1937 from the blood of a febrile woman in the West Nile province of Uganda. The virus is widely distributed in Africa, Europe, Australia, and Asia, and, since 1999, it has spread rapidly throughout the western hemisphere, including the USA, Canada, Mexico, and the Caribbean and into parts of Central and South America. Before 1994, outbreaks of West Nile virus were sporadic and occurred primarily in the Mediterranean region, Africa, and east Europe. Since 1994, outbreaks have occurred with a higher incidence of severe human disease, particularly affecting the nervous system. In North America, the virus has caused meningitis, encephalitis, and poliomyelitis, resulting in significant morbidity and mortality. The goal of this Review is to highlight recent advances in our understanding of West Nile virus virology, ecology, clinical disease, diagnosis, and development of potential vaccines and antiviral therapies.
UR - http://www.scopus.com/inward/record.url?scp=33846220327&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846220327&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(07)70030-3
DO - 10.1016/S1474-4422(07)70030-3
M3 - Review article
C2 - 17239804
AN - SCOPUS:33846220327
SN - 1474-4422
VL - 6
SP - 171
EP - 181
JO - Lancet Neurology
JF - Lancet Neurology
IS - 2
ER -